Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

BACKGROUND: Many patients with COVID-19 have been treated with plasma containing anti-SARS-CoV-2 antibodies. We aimed to evaluate the safety and efficacy of convalescent plasma therapy in patients admitted to hospital with COVID-19. METHODS: This randomised, controlled, open-label, platform trial (R...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8121538/
https://www.ncbi.nlm.nih.gov/pubmed/34000257
http://dx.doi.org/10.1016/S0140-6736(21)00897-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8121538/
https://www.ncbi.nlm.nih.gov/pubmed/34000257
http://dx.doi.org/10.1016/S0140-6736(21)00897-7

Ejemplares similares